Propanc Biopharma (PPCB) Cash & Current Investments (2015 - 2026)
Propanc Biopharma (PPCB) recorded Cash & Current Investments of $832,006 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $12,088 a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Cash & Current Investments (2015 - 2026) Analysis & Trends
Starting with fiscal Q4 2015, Propanc Biopharma's Cash & Current Investments history includes 42 quarters.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 226.1% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Current Investments came in at $12,088 in FY2025 (-42.7%), $21,085 in FY2024 (+109.9%), $10,047 in FY2023 (+147.0%) and $4,067 in FY2022 (+80.4%).
- The fiscal Q4 2026 figure is the highest quarterly Cash & Current Investments since fiscal Q3 2016.
- On a year-over-year basis, Cash & Current Investments rose in two of the last four quarters, with growth averaging 158.4%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 827.2% in fiscal Q3 2022, against a decline of 93.3% in fiscal Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Propanc Biopharma | 319,020.98 | -1.69 Mn | - | 832,006.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 832,006.00 |
| Dec 31, 2025 | 561,237.00 |
| Sep 30, 2025 | 602,737.00 |
| Jun 30, 2025 | 12,088.00 |
| Mar 31, 2025 | 50,760.00 |
| Dec 31, 2024 | 14,633.00 |
| Sep 30, 2024 | 9,268.00 |
| Jun 30, 2024 | 21,085.00 |
| Mar 31, 2024 | 6,222.00 |
| Dec 31, 2023 | 71,650.00 |
| Sep 30, 2023 | 6,625.00 |
| Jun 30, 2023 | 10,047.00 |
| Mar 31, 2023 | 93,241.00 |
| Dec 31, 2022 | 24,476.00 |
| Sep 30, 2022 | 19,396.00 |
| Jun 30, 2022 | 4,067.00 |
| Mar 31, 2022 | 133,885.00 |
| Dec 31, 2021 | 73,616.00 |
| Sep 30, 2021 | 45,817.00 |
| Jun 30, 2021 | 2,255.00 |
API Access
Propanc Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();